BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9357768)

  • 1. Regulation of vascular angiotensin II receptors by EGF.
    Ullian ME; Raymond JR; Willingham MC; Paul RV
    Am J Physiol; 1997 Oct; 273(4):C1241-9. PubMed ID: 9357768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor.
    Ullian ME; Webb JG; Chen R; Paul RV; Morinelli TA
    J Cell Physiol; 2004 Sep; 200(3):451-7. PubMed ID: 15254973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.
    Nickenig G; Murphy TJ
    Mol Pharmacol; 1994 Oct; 46(4):653-9. PubMed ID: 7969043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces.
    Gouni-Berthold I; Berthold HK; Seewald S; Seul C; Ko Y; Vetter H; Sachinidis A
    Scand J Clin Lab Invest; 2000 Dec; 60(8):723-31. PubMed ID: 11218155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Eguchi S; Numaguchi K; Iwasaki H; Matsumoto T; Yamakawa T; Utsunomiya H; Motley ED; Kawakatsu H; Owada KM; Hirata Y; Marumo F; Inagami T
    J Biol Chem; 1998 Apr; 273(15):8890-6. PubMed ID: 9535870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.
    Sachinidis A; el-Haschimi K; Ko Y; Seul C; Düsing R; Vetter H
    Biochem Pharmacol; 1996 Jul; 52(1):123-6. PubMed ID: 8678895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells.
    Wang X; Murphy TJ
    Mol Pharmacol; 1998 Sep; 54(3):514-24. PubMed ID: 9730910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of vasoconstrictor-stimulated basic fibroblast growth factor expression from hypertrophic growth in cultured vascular smooth muscle cells. Relevant roles of protein kinase C.
    Ali S; Becker MW; Davis MG; Dorn GW
    Circ Res; 1994 Nov; 75(5):836-43. PubMed ID: 7923629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor and platelet-derived growth factor-BB induce a stable increase in the activity of low density lipoprotein receptor-related protein in vascular smooth muscle cells by altering receptor distribution and recycling.
    Weaver AM; McCabe M; Kim I; Allietta MM; Gonias SL
    J Biol Chem; 1996 Oct; 271(40):24894-900. PubMed ID: 8798766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K depletion alters angiotensin II receptor expression in vascular smooth muscle cells.
    Linas SL; Marzec-Calvert R; Ullian ME
    Am J Physiol; 1990 May; 258(5 Pt 1):C849-54. PubMed ID: 2333982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
    Kai H; Fukui T; Lassègue B; Shah A; Minieri CA; Griendling KK
    Mol Pharmacol; 1996 Jan; 49(1):96-104. PubMed ID: 8569718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth.
    Freeman EJ; Chisolm GM; Ferrario CM; Tallant EA
    Hypertension; 1996 Jul; 28(1):104-8. PubMed ID: 8675248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta.
    Stouffer GA; Owens GK
    Circ Res; 1992 Apr; 70(4):820-8. PubMed ID: 1551205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
    Ushio-Fukai M; Griendling KK; Becker PL; Hilenski L; Halleran S; Alexander RW
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):489-95. PubMed ID: 11304462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
    Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells.
    Silfani TN; Freeman EJ
    Arch Biochem Biophys; 2002 Jun; 402(1):84-93. PubMed ID: 12051686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.